Cunha-Filho IT, Henson H, Protas EJ: Reliability of a portable gas analyzer during a 5-min walk test. Am J Phys Med Rehabil 2007;86:469 -473. Objective: To determine the reliability of a gas analyzer while assessing oxygen consumption (VO 2 ) during a 5-min walking test.
The variability ofVO 2 measures has limited their usefulness as a clinical tool. 8 ,9V O 2 can vary from trial to trial, even when it is assessed using controlled workloads, such as observed in protocols designed for bike or treadmill ergometry. 10 Measurements ofVO 2 during functional activities, especially in rehabilitation settings, may add further variability when individuals with impairments perform a task.
Measurement of gait energy expenditure, that is, the amount of oxygen consumed during walking, has been used to evaluate intervention outcomes with patients undergoing neurological, 11, 12 cardiopulmonary, 13 and orthopedic rehabilitation, 14 as well as with geriatric populations. 15 However, measures oḟ VO 2 during walking are influenced by gait speed; consequently, the energy expenditure during overground walking may result in large variability across different trials. 16 Evaluation ofVO 2 while walking on short walkways such as 5-and 10-m lengths over a specified time period may impose a different source of variability by requiring frequent turns on the short walkway. Yet, the use of such short walkways is commonly observed in clinical settings. These short walkways have been used to assess endurance in more impaired individuals 11, 12 and to evaluate kinematic aspects of gait. 17, 18 Hence, the investigation of the variability inVO 2 with healthy individuals while walking on short walkways is needed to establish standards. The purpose of this study was to determine the reliability of the assessment ofVO 2 , distance walked, gait speed, and gait energy costs during walking, using a portable gas analyzer.
MATERIALS AND METHODS Subjects
Forty healthy individuals, whose ages ranged from 18 to 55 yrs old, were recruited among the students and staff from Texas Woman's University, Houston Campus, and from the Michael E. Debakey Veteran's Affairs Medical Center. The participants voluntarily joined the study after providing a signed, written informed consent. The study was approved by the institutional review board for human subject research for Baylor College of Medicine and Affiliated Hospitals.
Instrumentation
The Aerosport model KB1-C is a lightweight (1.25 kg) portable system that consists of a facemask for collecting expired air, a pneumotach, sensors for analyzing the O 2 and CO 2 content of expired air, a heart rate (HR) monitor with a cheststrap transmitter worn around the chest, and a battery pack. The KB1-C system performs O 2 and CO 2 analysis on a continuous basis using a patented system called electronic variable sampling. As air is exhaled through the pneumotach, a proportional microsample is drawn off into a mixing chamber inside the unit. The pneumotach has three flow ranges; for this study, the medium flow range (10 -120 liters/min) was selected because walking is not a strenuous activity. A volume of the mixed sample is emitted to the O 2 and CO 2 detectors. After gas analysis and flow integration, the gas is exported out the back of the system to ambient air. The O 2 concentration is measured using a galvanic fuel cell, and the CO 2 concentration is measured by nondispersive infrared analysis. These are the same methods used in conventional metabolic systems. 19 Expired flow is measured using a flat-plate orifice pneumotach, and ventilatory volume is calculated by digital integration.VO 2 and rate of carbon dioxide production (VCO 2 ) are calculated according to standard equations for indirect calorimetry. The validity of the KB1-C system was tested against the traditional computer-based metabolic measurement cart to evaluateVO 2 using 12 subjects who performed maximal graded exercise tests on a treadmill (Pearson correlation coefficient of 0.9). 20 Before each assessment, the pneumotach was calibrated with a 3-liter calibration syringe. The gas analyzers were calibrated according to the manufacturer's specifications using a calibration gas of known O 2 and CO 2 composition [(12% O 2 and 5% CO 2 , and balance nitrogen (N 2 )]. The KB1-C system was set to sample data every 20 secs for ventilation, fractions of inspired O 2 and expired CO 2 , heart rate, respiratory exchange ratio,VO 2 , andVCO 2 . Information such as age, gender, height, and weight was entered for each participant in the portable gas analyzer before each measurement.
Protocol
Before beginning the test, each participant was instructed to walk back and forth, at his or her usual gait speed, on a 5-m walkway for 3 mins to become acquainted with the procedure. The subject was then allowed to rest for 6 mins.
Each subject was then fitted with the portable gas analyzer, a facemask, and a chest-band heart rate transmitter. The participants was asked to walk on the 5-m walkway for a total time of 5 mins. Because the 5-min walking test has been used for both neurologically and orthopedically compromised populations, this study used 5 mins to standardize this test on individuals without gait impairments. 11, 21 The floor was marked in 1-m intervals, and the subjects were asked to walk back and forth at their usual gait velocity throughout the test. No formal encouragement was given to the participants, but they were told that they were doing fine and to keep it up with the walking. A stopwatch was used to measure the walking time. The 5-m walkway was used because it is short enough to allow for the evaluation of walking when larger spaces are not available in various clinical settings and in home care.
After this first trial, the mask was taken off, and the recorded information was printed. The participant was allowed to rest for 12 mins before performing a second trial. The gas analyzer was again recalibrated, the facemask was repositioned, and the subject then completed a second trial.
The variable of primary interest was rate oḟ VO 2 , which was calculated as follows. Samples oḟ VO 2 were recorded every 20 secs. Therefore, in each minute, there were three recordings oḟ VO 2 .
11,21 These three recordings were averaged to obtain the amount of oxygen consumed for each minute. The values obtained at each minute were added up, and the statistical analyses were done with this sum. Data were recorded in milliliters of oxygen per kilogram of body weight per 5 mins walked. This variable was defined as the total gait energy expenditure (EE). The total distance covered during each trial of the 5-min walk was also recorded. The walk distance (D) was recorded in meters. The oxygen consumed by meter walked, the gait energy cost (C), was also calculated. It was obtained by dividing EE by the total meters walked during the 5-min walk. C was recorded in milliliters of oxygen per kilogram per meter. Gait speed (S) was calculated in meters per second by dividing D by 300 secs.
Sample Size Calculation
In our lab, we found a test-retest reliability coefficient of 0.75 for EE, using nine subjects. For this study, we projected an acceptable level testretest reliability coefficient to be at least 0.90. Through Fisher Z transformation, the effect-size index (q) obtained with these two correlation coefficients was 0.50. Therefore, a sample of at least 28 paired observations was required to find a q of 0.50 with a power of 0.80 and an alpha level (one sided) of 0.05.
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Statistical Analysis
Descriptive statistics were used to characterize the outcome variables. Mean differences between trials were checked with ANOVA for each variable. The reliability study was conducted by the intraclass correlation coefficient, model 2,1 (ICC 2,1 ) and by the coefficient of variation (CV) based on the method error. 22 An alpha level of 5% was considered significant. Standard error of measurement (SEM), which is also an indication of absolute reliability, was calculated as the square root of the absolute error variance. 23, 24 It was used to calculated the smallest detectable difference (SDD) expected when two measurements are conducted. The SDD has clinical significance because it indicates how much change is expected from an intervention to generate scores that are beyond mere chance. The SDD obtained between two independent measures of a subject has a 95% CI equal to 1.96x͌2xSEM. 17 All statistical analyses were performed with the SPSS software package.
RESULTS
Forty healthy subjects (25 females and 15 males) participated in the study. Their mean age was 33.0 Ϯ 8.96 yrs, ranging from 18 to 53 yrs. Table 1 
·5 min
Ϫ1 (P ϭ 0.01) ( Table 1 ). The reliability coefficient was high and statistically significant (ICC 2,1 ϭ 0.99; P ϭ 0.00005, 0.005). The variability of this measurement across two trials was CV ϭ 7.4%. The SEM for EE was 3.24, and the SDD for this variable had a 95% CI of Ϯ8.98 ml·kg Ϫ1 ·5 min Ϫ1 . Participants covered very similar distances across trials during the 5-min walk. The reliability of this measure was high and was statistically significant (ICC 2,1 ϭ 0.92; P Ͻ 0.00005, 0.005). The CV indicates that participants had low variability when both trials were considered (3.6%). The SEM was 9.51, and the 95% CI for the SDD was Ϯ26.35 m.
There was a small but significant difference in the mean C values between trials. The reliability of this measurement was lower (ICC 2,1 ϭ 0.67, P ϭ 0.0005), and the CV across measures was 9%. The SEM is 0.01, 0.414, and the SDD had a 95% CI of Ϯ0.04 in milliliters of oxygen per kilogram per meter. There was very little variability between subjects with this variable, as seen in Table 1 . The range (difference between maximal and minimum values) observed with this variable, considering both trials, was only 0.11 m·s Ϫ1 . Participants walked at similar S values across trials, and the reliability coefficient was high (ICC 2,1 ϭ 0.92; P ϭ 0.00005, 0.005) and low CV (3.2%). The SEM was 0.032, and the SDD 95% CI was Ϯ0.09 m·s
Ϫ1
.
DISCUSSION
The primary objective of this study was to use a portable gas analyzer to establish the reliability of measures of the rate ofVO 2 during walking, and to characterize the reliability of the D and S values during the 5-min walk test. Because this was a self-paced walking test conducted in a 5-m walkway, it required many turns. Therefore, we reported theVO 2 by averaging three readings during each minute within the test to minimize the variability in this measure. Even though each partici-pant was instructed to keep the same self-selected speed throughout the test, there is no guarantee that the speed was constant, especially when changes in acceleration from so many turns occurred. This test was performed over a 5-m distance, and there were frequent changes in acceleration when the participant approached and moved away from turns. Therefore, to minimize the variability inVO 2 attributable to variations in S, the oxygen consumed throughout each minute was analyzed. Another source of variability with this measurement may be the lack of stability in the initial values ofVO 2 during the 5-min walk. Thus, the oxygen deficit present before a steady state is reached during exercise may represent a significant part of the total EE. 10 Some studies even suggest thatVO 2 should be reported as the net consumption (the increasedVO 2 above resting values) compared with the grossVO 2 .
16,25 Nonetheless, there was a small but statistically significant difference between trials. Participants consumed less oxygen in the second trial; this may be attributable to a learning effect rather than the lack of a steady state in the initial few minutes of the test. The ICC for the total EE indicates that this measurement is reliable.
This study also used the method error as an adjunct to test-retest reliability because it reflected the percentage of variation from trial to trial, 23 which is not given by the ICC. , according to the SDD. The 5-min walking test demonstrates a high reliability coefficient for D, and very low variability across trials. The CV of 3.6% indicates that walking 300 m in one trial might produce an expected variability of 10.8 m in the next trial. The SDD indicates that the walking distance in a 5-min walk could increase or decrease by 26.35 m, for a meaningful change.
In this study, the mean S of 0.89 m·s Ϫ1 might be considered a slow walking velocity for the participants' age range. According to Waters and Mulroy, 25 most adults prefer to walk at speeds ranging from 1.0 to 1.67 m·s Ϫ1 , and these values are generally determined over short distances of 5-10 m. The average slower walking velocities observed in our study may reflect the frequent changes in acceleration while turning at each end of the walkway. Despite this, it is possible to obtain highly reliable S values with low variability across trials in the 5-min walk test. The CV of 3.2% indicates that an S value of 0.7 m·s Ϫ1 in one trial could vary by 0.24 m·s Ϫ1 in another trial. A statistically significant difference could occur with an increased or decreased S value of 0.09 m·s Ϫ1 . The economy of walking, as expressed by the C variable, was the one variable that generated the lowest coefficient of reliability (ICC 2,1 ϭ 0.67) and a variability across trials of 9%. The low ICC value with this variable may be explained by the low between-subject variance observed. Whenever a restriction of range is present in a variable, low levels of reliability coefficients are found. Therefore, the CV across trials is preferable to evaluate the reliability of this variable, because the method error is not affected by a lack of variation in the raw scores. Variability of 9% is still an indicator that the measurement is reliable. Again, this value indicates that if the obtained value of oxygen consumed by meter walked in one assessment were 0. 15 
CONCLUSION
This study indicates that the KB1-C system is a reliable device for measuringVO 2 during self-selected walking speeds. Further, the 5-min walk test as described produced reliable values for D and S.
